StonvexLoading…
StonvexStonvexStonvexCore line items from XERS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $291.85M | $203.07M | $163.91M | $110.25M |
Operating Income | $24.90M | $-33.65M | $-44.01M | $-81.94M |
Net Income | $554.00K | $-54.84M | $-62.26M | $-94.66M |
EPS (Diluted) | $0.00 | $-0.37 | $-0.45 | $-0.70 |
Total Assets | $383.53M | $323.06M | $322.60M | $344.52M |
Total Liabilities | $369.84M | $352.68M | $329.38M | $299.33M |
Cash & Equivalents | $111.04M | $71.62M | $67.45M | $121.97M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 166.22M | 149.43M | 138.13M | 136.27M |